Literature DB >> 27340094

Application of mouse model for effective evaluation of foot-and-mouth disease vaccine.

Seo-Yong Lee1, Mi-Kyeong Ko2, Kwang-Nyeong Lee2, Joo-Hyung Choi2, Su-Hwa You2, Hyun-Mi Pyo2, Myoung-Heon Lee2, Byounghan Kim2, Jong-Soo Lee3, Jong-Hyeon Park4.   

Abstract

Efficacy evaluation of foot-and-mouth disease (FMD) vaccines has been conducted in target animals such as cows and pigs. In particular, handling FMD virus requires a high level of biosafety management and facilities to contain the virulent viruses. The lack of a laboratory animal model has resulted in inconvenience when it comes to using target animals for vaccine evaluation, bringing about increased cost, time and labor for the experiments. The FMD mouse model has been studied, but most FMD virus (FMDV) strains are not known to cause disease in adult mice. In the present study, we created a series of challenge viruses that are lethal to adult C57BL/6 mice. FMDV types O, A, and Asia1, which are related to frequent FMD outbreaks, were adapted for mice and the pathogenesis of each virus was evaluated in the mouse model. Challenge experiments after vaccination using in-house and commercial vaccines demonstrated vaccine-mediated protection in a dose-dependent manner. In conclusion, we propose that FMD vaccine evaluation should be carried out using mouse-adapted challenge viruses as a swift, effective efficacy test of experimental or commercial vaccines.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Challenge; Evaluation; Foot-and-mouth disease; Mouse FMD model; Mouse-adapted FMDV; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27340094     DOI: 10.1016/j.vaccine.2016.06.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

1.  A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.

Authors:  Zaixue Jiang; Yaozhong Zhang; Huayuan Lin; Qingqiu Cheng; Xiaomei Lu; Wenkuan Liu; Rong Zhou; Baimao Zhong; Xingui Tian
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.